Nucleus Reuniens Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Nucleus Reuniens Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Mermaid diagram (expand to render)
The Nucleus Reuniens (Re) is a midline thalamic nucleus that serves as a critical relay between the [hippocampus](/brain-regions/hippocampus) and prefrontal [cortex](/brain-regions/cortex). As part of the ventral midline thalamic group, it plays a pivotal role in hippocampal-cortical communication, memory consolidation, and executive function. This nucleus has emerged as an important structure in understanding neurodegenerative diseases, particularly [Alzheimer's disease](/diseases/alzheimers-disease), where hippocampal-cortical disconnectivity is a hallmark. [@roy2017]
Morphology and Markers
Cellular Morphology
Cell types: Mixed population of projection [neurons](/entities/neurons) and interneurons
Soma size: Medium-sized neurons (15-25 μm)
Dendritic architecture: Radially oriented dendrites with spiny branches
Axonal projections: Bifurcating axons targeting both hippocampus and prefrontal cortex
Nissl pattern: Moderately dense cellular population in midline thalamus
Molecular Markers
Calbindin D-28K (CALB1): Expressed in majority of reuniens neurons
Transcranial magnetic stimulation (TMS): Target for enhancing hippocampal-cortical connectivity
Deep brain stimulation: Investigational target for memory enhancement
Pharmacological: NMDA modulators to enhance thalamic relay function
Transcriptomic Profile
Key Differentially Expressed Genes
TBR1: Thalamic relay neuron marker
CALB1: Calcium-binding protein (calbindin)
GAD1/GAD2: GABAergic interneuron markers
SLC17A6 (VGLUT2): Vesicular glutamate transporter
GRM1: Metabotropic glutamate receptor 1
HTR2A: Serotonin 2A receptor
ADRA1A: Alpha-1 adrenergic receptor
Regional Specificity
Distinct from adjacent nuclei (rhomboid nucleus, centromedian nucleus)
Similar molecular profile to other ventral midline thalamic nuclei
Unique expression of certain hippocampal-projecting markers
Research Directions
Experimental Approaches
Optogenetics: Circuit-specific manipulation of reuniens-hippocampal pathways
Chemogenetics: DREADD manipulation of reuniens activity
Tracing studies: Viral tracing of hippocampal-prefrontal circuits
Clinical Relevance
Biomarkers: Functional connectivity as early biomarker for AD
Treatment targets: Neuromodulation for memory disorders
Network-based approaches: Graph theoretical analysis of thalamo-cortical networks
Background
The study of Nucleus Reuniens Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@bolkan2017]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@ito2024]